CN104212998A - 一种Zn-Mg系锌合金及其制备方法与应用 - Google Patents
一种Zn-Mg系锌合金及其制备方法与应用 Download PDFInfo
- Publication number
- CN104212998A CN104212998A CN201410415524.7A CN201410415524A CN104212998A CN 104212998 A CN104212998 A CN 104212998A CN 201410415524 A CN201410415524 A CN 201410415524A CN 104212998 A CN104212998 A CN 104212998A
- Authority
- CN
- China
- Prior art keywords
- zinc alloy
- alloy
- preparation
- trace element
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910009369 Zn Mg Inorganic materials 0.000 title claims abstract description 90
- 229910007573 Zn-Mg Inorganic materials 0.000 title claims abstract description 90
- 229910001297 Zn alloy Inorganic materials 0.000 title claims abstract description 70
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000011701 zinc Substances 0.000 claims abstract description 45
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 40
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 33
- 239000007943 implant Substances 0.000 claims abstract description 28
- 239000011575 calcium Substances 0.000 claims abstract description 10
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 6
- 229910052712 strontium Inorganic materials 0.000 claims abstract description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 5
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims abstract description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052744 lithium Inorganic materials 0.000 claims abstract description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 3
- 239000011574 phosphorus Substances 0.000 claims abstract description 3
- 229910052761 rare earth metal Inorganic materials 0.000 claims abstract description 3
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 3
- 239000010703 silicon Substances 0.000 claims abstract description 3
- 229910052709 silver Inorganic materials 0.000 claims abstract description 3
- 239000004332 silver Substances 0.000 claims abstract description 3
- 229910052718 tin Inorganic materials 0.000 claims abstract description 3
- 239000011777 magnesium Substances 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 29
- 210000000988 bone and bone Anatomy 0.000 claims description 23
- 238000000576 coating method Methods 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 20
- 239000011248 coating agent Substances 0.000 claims description 19
- 238000005096 rolling process Methods 0.000 claims description 15
- 239000011573 trace mineral Substances 0.000 claims description 15
- 235000013619 trace mineral Nutrition 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 13
- 238000005524 ceramic coating Methods 0.000 claims description 11
- 229920002521 macromolecule Polymers 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 210000001124 body fluid Anatomy 0.000 claims description 8
- 239000010839 body fluid Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 238000001125 extrusion Methods 0.000 claims description 8
- 238000005245 sintering Methods 0.000 claims description 8
- 238000002844 melting Methods 0.000 claims description 7
- 230000008018 melting Effects 0.000 claims description 7
- 238000005242 forging Methods 0.000 claims description 6
- 238000005098 hot rolling Methods 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000007712 rapid solidification Methods 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 238000007731 hot pressing Methods 0.000 claims description 4
- 230000010100 anticoagulation Effects 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims description 2
- 238000005345 coagulation Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 30
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 238000001727 in vivo Methods 0.000 abstract description 4
- 229910021645 metal ion Inorganic materials 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 230000008468 bone growth Effects 0.000 abstract 1
- 239000000956 alloy Substances 0.000 description 88
- 229910045601 alloy Inorganic materials 0.000 description 87
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 22
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 16
- 238000007906 compression Methods 0.000 description 16
- 230000006835 compression Effects 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 11
- 230000007797 corrosion Effects 0.000 description 10
- 238000005260 corrosion Methods 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- -1 poly(lactic acid) Polymers 0.000 description 8
- 210000001772 blood platelet Anatomy 0.000 description 7
- 238000005266 casting Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000007769 metal material Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000005507 spraying Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229910000861 Mg alloy Inorganic materials 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 4
- 208000008167 Magnesium Deficiency Diseases 0.000 description 4
- 244000137852 Petrea volubilis Species 0.000 description 4
- 229920002730 Poly(butyl cyanoacrylate) Polymers 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 229960000935 dehydrated alcohol Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000004764 magnesium deficiency Nutrition 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 238000005498 polishing Methods 0.000 description 4
- 229920001432 poly(L-lactide) Polymers 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 229920001610 polycaprolactone Polymers 0.000 description 4
- 239000004632 polycaprolactone Substances 0.000 description 4
- 239000004633 polyglycolic acid Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 239000012890 simulated body fluid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000004506 ultrasonic cleaning Methods 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 229920002988 biodegradable polymer Polymers 0.000 description 3
- 239000004621 biodegradable polymer Substances 0.000 description 3
- 238000001311 chemical methods and process Methods 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 239000008151 electrolyte solution Substances 0.000 description 2
- 210000003725 endotheliocyte Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000001027 hydrothermal synthesis Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002103 nanocoating Substances 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 229960001319 parathyroid hormone Drugs 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000007750 plasma spraying Methods 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
- 229960002930 sirolimus Drugs 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 229910000882 Ca alloy Inorganic materials 0.000 description 1
- 241000722676 Calocedrus Species 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021027 Hypomagnesaemia Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 229910001182 Mo alloy Inorganic materials 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- OYCDTPQIKJZGBS-UHFFFAOYSA-N P(O)(O)(O)=O.[O] Chemical compound P(O)(O)(O)=O.[O] OYCDTPQIKJZGBS-UHFFFAOYSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229910000883 Ti6Al4V Inorganic materials 0.000 description 1
- 229910010380 TiNi Inorganic materials 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000010405 anode material Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000002977 biomimetic material Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001652 electrophoretic deposition Methods 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 229960005167 everolimus Drugs 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000000713 high-energy ball milling Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000010603 microCT Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- CUXQLKLUPGTTKL-UHFFFAOYSA-M microcosmic salt Chemical compound [NH4+].[Na+].OP([O-])([O-])=O CUXQLKLUPGTTKL-UHFFFAOYSA-M 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 210000001243 pseudopodia Anatomy 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- AVPCPPOOQICIRJ-UHFFFAOYSA-L sodium glycerol 2-phosphate Chemical compound [Na+].[Na+].OCC(CO)OP([O-])([O-])=O AVPCPPOOQICIRJ-UHFFFAOYSA-L 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
试样编号 | 抗拉强度/MPa | 屈服强度/MPa | 延伸率/% |
Zn-1Mg铸锭 | 170.54 | 132.35 | 1.745 |
Zn-5Mg铸锭 | 90.37 | 63.43 | 0.521 |
Zn-1Mg-0.5Sr铸锭 | 185.64 | 153.47 | 1.686 |
Zn-1Mg-1Sr铸锭 | 201.54 | 170.27 | 1.838 |
Zn-1Mg轧板 | 270.33 | 210.72 | 12.858 |
Zn-1Mg棒材 | 316.65 | 257.42 | 10.438 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410415524.7A CN104212998B (zh) | 2014-08-21 | 2014-08-21 | 一种Zn‑Mg系锌合金及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410415524.7A CN104212998B (zh) | 2014-08-21 | 2014-08-21 | 一种Zn‑Mg系锌合金及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104212998A true CN104212998A (zh) | 2014-12-17 |
CN104212998B CN104212998B (zh) | 2017-02-01 |
Family
ID=52094899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410415524.7A Active CN104212998B (zh) | 2014-08-21 | 2014-08-21 | 一种Zn‑Mg系锌合金及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104212998B (zh) |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651664A (zh) * | 2015-03-13 | 2015-05-27 | 周功耀 | 一种人体可降解的耐蚀高强韧Zn‐Fe‐RE系锌合金及其应用 |
CN105648272A (zh) * | 2016-02-01 | 2016-06-08 | 中国科学院宁波材料技术与工程研究所 | 一种可降解的锌合金材料及其制备方法和应用 |
WO2016152908A1 (ja) * | 2015-03-26 | 2016-09-29 | テルモ株式会社 | 亜鉛系合金からなる医療用インプラント、およびその製造方法 |
WO2016152909A1 (ja) * | 2015-03-26 | 2016-09-29 | テルモ株式会社 | 亜鉛系合金からなる医療用インプラント |
CN105986146A (zh) * | 2015-01-30 | 2016-10-05 | 乐普(北京)医疗器械股份有限公司 | 一种可降解医用植入金属材料及其制备方法 |
CN106606806A (zh) * | 2015-10-21 | 2017-05-03 | 北京大学 | 一种Zn-Mg1Ca系锌合金及其制备方法与应用 |
CN106606800A (zh) * | 2015-10-21 | 2017-05-03 | 北京大学 | 一种Zn-Fe系锌合金及其制备方法与应用 |
CN106676327A (zh) * | 2017-03-14 | 2017-05-17 | 郑州大学 | 一种新型可生物降解Zn‑Mg‑Nd锌合金植入材料及其制备方法 |
CN106890356A (zh) * | 2016-03-10 | 2017-06-27 | 山东瑞安泰医疗技术有限公司 | 一种可降解的锌基合金植入材料及其制备方法与应用 |
WO2017107858A1 (zh) * | 2015-12-23 | 2017-06-29 | 上海微创医疗器械(集团)有限公司 | 一种合金材料及其应用 |
WO2017117922A1 (zh) * | 2016-01-08 | 2017-07-13 | 先健科技(深圳)有限公司 | 植入式器械 |
WO2016120338A3 (de) * | 2015-01-28 | 2017-08-03 | Limedion GmbH | Biodegradierbare legierung sowie deren herstellung und verwendung, insbesondere zur herstellung von stents und anderen implantaten |
WO2017176077A1 (ko) * | 2016-04-07 | 2017-10-12 | 랩앤피플주식회사 | 생체분해성 금속을 이용한 마이크로 니들 |
KR20170115449A (ko) * | 2016-04-07 | 2017-10-17 | 랩앤피플주식회사 | 생체분해성 금속을 이용한 마이크로 니들 |
CN107460371A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn-Li系锌合金及其制备方法与应用 |
CN107460372A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn‑Mn系锌合金及其制备方法与应用 |
CN107456610A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn-Ag系锌合金及其制备方法与应用 |
CN107456601A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn-Cu系锌合金及其制备方法与应用 |
CN107855528A (zh) * | 2017-10-31 | 2018-03-30 | 太原理工大学 | 一种多孔锌镁合金/羟基磷灰石复合材料的制备方法 |
CN108277386A (zh) * | 2018-03-23 | 2018-07-13 | 北京大学 | 一种Zn-Li-Mg系锌合金及其制备方法与应用 |
CN108411158A (zh) * | 2018-03-05 | 2018-08-17 | 中国科学院宁波工业技术研究院慈溪生物医学工程研究所 | 一种生物可降解的Zn-Mg-Zr合金材料、制备方法及应用 |
CN108577922A (zh) * | 2018-02-26 | 2018-09-28 | 天津理工大学 | 一种可降解锌合金腹腔镜止血夹及其制备方法 |
CN109097629A (zh) * | 2018-09-21 | 2018-12-28 | 北京科技大学 | 一种可生物降解Zn-Mo系锌合金及其制备方法 |
CN109938818A (zh) * | 2019-01-11 | 2019-06-28 | 中国医学科学院北京协和医院 | 可降解的镁合金髌骨爪及其制备方法 |
CN110273084A (zh) * | 2019-07-24 | 2019-09-24 | 西安交通大学 | 一种可生物降解锌合金的制备方法 |
CN111020246A (zh) * | 2019-11-19 | 2020-04-17 | 河海大学 | 一种基于超细三相共晶组织增强的高强韧医用生物可降解锌合金及其制备方法 |
CN111020254A (zh) * | 2019-11-19 | 2020-04-17 | 河海大学 | 一种低合金化高强韧易编织可降解医用锌合金丝材及其制备方法 |
CN111331128A (zh) * | 2020-04-16 | 2020-06-26 | 长沙镁捷新材料科技有限公司 | 一种通过金属粉末烧结制备锌合金可降解材料的方法 |
CN111778428A (zh) * | 2020-07-16 | 2020-10-16 | 扬州大学 | 一种Mg-Zn-Sr纳米晶及其制备方法 |
CN111876633A (zh) * | 2020-07-31 | 2020-11-03 | 湖南华耀百奥医疗科技有限公司 | 一种医用可降解高熵合金及其制备方法与应用 |
WO2021057140A1 (zh) * | 2019-09-23 | 2021-04-01 | 上海交通大学 | 医用锌基材料表面的镁-磷生物相容性涂层及制备和用途 |
CN112899527A (zh) * | 2021-01-20 | 2021-06-04 | 湖南华锐科技集团股份有限公司 | 一种可降解锌合金棒材及其制备方法 |
CN113416867A (zh) * | 2021-06-16 | 2021-09-21 | 东北大学 | 一种可用于可降解心血管支架的锌合金管材制备方法 |
CN114086030A (zh) * | 2021-11-22 | 2022-02-25 | 江苏时代铭阳生物新技术研究院有限公司 | 一种可降解高相容性的生物医用材料及其制备方法 |
CN114717447A (zh) * | 2022-05-19 | 2022-07-08 | 中南大学 | 一种超细晶生物可降解锌合金及其制备方法和应用 |
CN114836653A (zh) * | 2022-04-20 | 2022-08-02 | 柳州华锡有色设计研究院有限责任公司 | 一种Zn-Al-Mg-RE热镀合金及其制备方法 |
CN115181874A (zh) * | 2022-08-04 | 2022-10-14 | 北京科技大学 | 一种在锌合金表面生成碳酸盐保护层的方法及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62112766A (ja) * | 1985-11-11 | 1987-05-23 | Nikko Aen Kk | 溶融亜鉛メツキ用亜鉛合金及びその使用方法 |
CN102119035A (zh) * | 2008-01-17 | 2011-07-06 | 香港大学 | 用于组织工程的植入体 |
CN102614545A (zh) * | 2012-03-15 | 2012-08-01 | 河南师范大学 | 一种金属基植入体三元复合涂层材料及其制备方法 |
CN102727937A (zh) * | 2012-06-28 | 2012-10-17 | 哈尔滨工程大学 | 可生物降解锌或锌合金与多孔双相磷酸钙复合材料及其制法 |
CN102978495A (zh) * | 2012-12-13 | 2013-03-20 | 北京大学 | 一种Mg-Sr-Zn系合金及其制备方法 |
CN103103537A (zh) * | 2013-02-28 | 2013-05-15 | 青岛双瑞海洋环境工程股份有限公司 | 一种新型的热海水环境中的锌合金牺牲阳极 |
KR20130121295A (ko) * | 2012-04-27 | 2013-11-06 | 김석환 | 경도와 인장강도가 향상된 아연-마그네슘 합금 |
-
2014
- 2014-08-21 CN CN201410415524.7A patent/CN104212998B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62112766A (ja) * | 1985-11-11 | 1987-05-23 | Nikko Aen Kk | 溶融亜鉛メツキ用亜鉛合金及びその使用方法 |
CN102119035A (zh) * | 2008-01-17 | 2011-07-06 | 香港大学 | 用于组织工程的植入体 |
CN102614545A (zh) * | 2012-03-15 | 2012-08-01 | 河南师范大学 | 一种金属基植入体三元复合涂层材料及其制备方法 |
KR20130121295A (ko) * | 2012-04-27 | 2013-11-06 | 김석환 | 경도와 인장강도가 향상된 아연-마그네슘 합금 |
CN102727937A (zh) * | 2012-06-28 | 2012-10-17 | 哈尔滨工程大学 | 可生物降解锌或锌合金与多孔双相磷酸钙复合材料及其制法 |
CN102978495A (zh) * | 2012-12-13 | 2013-03-20 | 北京大学 | 一种Mg-Sr-Zn系合金及其制备方法 |
CN103103537A (zh) * | 2013-02-28 | 2013-05-15 | 青岛双瑞海洋环境工程股份有限公司 | 一种新型的热海水环境中的锌合金牺牲阳极 |
Cited By (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016120338A3 (de) * | 2015-01-28 | 2017-08-03 | Limedion GmbH | Biodegradierbare legierung sowie deren herstellung und verwendung, insbesondere zur herstellung von stents und anderen implantaten |
CN105986146A (zh) * | 2015-01-30 | 2016-10-05 | 乐普(北京)医疗器械股份有限公司 | 一种可降解医用植入金属材料及其制备方法 |
CN104651664A (zh) * | 2015-03-13 | 2015-05-27 | 周功耀 | 一种人体可降解的耐蚀高强韧Zn‐Fe‐RE系锌合金及其应用 |
CN104651664B (zh) * | 2015-03-13 | 2017-04-05 | 西安爱德万思医疗科技有限公司 | 一种人体可降解的耐蚀高强韧Zn‐Fe‐RE系锌合金及其应用 |
WO2016152908A1 (ja) * | 2015-03-26 | 2016-09-29 | テルモ株式会社 | 亜鉛系合金からなる医療用インプラント、およびその製造方法 |
WO2016152909A1 (ja) * | 2015-03-26 | 2016-09-29 | テルモ株式会社 | 亜鉛系合金からなる医療用インプラント |
CN106606806A (zh) * | 2015-10-21 | 2017-05-03 | 北京大学 | 一种Zn-Mg1Ca系锌合金及其制备方法与应用 |
CN106606800A (zh) * | 2015-10-21 | 2017-05-03 | 北京大学 | 一种Zn-Fe系锌合金及其制备方法与应用 |
CN106606800B (zh) * | 2015-10-21 | 2019-05-14 | 北京大学 | 一种Zn-Fe系锌合金及其制备方法与应用 |
CN106606806B (zh) * | 2015-10-21 | 2019-07-09 | 北京大学 | 一种Zn-Mg1Ca系锌合金及其制备方法与应用 |
EP3395971A4 (en) * | 2015-12-23 | 2018-11-14 | Shanghai MicroPort Medical (Group) Co., Ltd. | Alloy material and application thereof |
WO2017107858A1 (zh) * | 2015-12-23 | 2017-06-29 | 上海微创医疗器械(集团)有限公司 | 一种合金材料及其应用 |
CN106906381A (zh) * | 2015-12-23 | 2017-06-30 | 上海微创医疗器械(集团)有限公司 | 一种合金材料及其应用 |
US20190003016A1 (en) * | 2015-12-23 | 2019-01-03 | Shanghai Microport Medical (Group) Co., Ltd. | Alloy material and application thereof |
US10799612B2 (en) | 2016-01-08 | 2020-10-13 | Lifetech Scientific (Shenzhen) Co. Ltd. | Implanted device |
WO2017117922A1 (zh) * | 2016-01-08 | 2017-07-13 | 先健科技(深圳)有限公司 | 植入式器械 |
CN105648272A (zh) * | 2016-02-01 | 2016-06-08 | 中国科学院宁波材料技术与工程研究所 | 一种可降解的锌合金材料及其制备方法和应用 |
CN106890356B (zh) * | 2016-03-10 | 2020-07-24 | 山东瑞安泰医疗技术有限公司 | 一种可降解的锌基合金植入材料及其制备方法与应用 |
CN106890356A (zh) * | 2016-03-10 | 2017-06-27 | 山东瑞安泰医疗技术有限公司 | 一种可降解的锌基合金植入材料及其制备方法与应用 |
KR20190075033A (ko) * | 2016-04-07 | 2019-06-28 | 랩앤피플주식회사 | 생체분해성 금속을 이용한 마이크로 니들 |
KR20170115449A (ko) * | 2016-04-07 | 2017-10-17 | 랩앤피플주식회사 | 생체분해성 금속을 이용한 마이크로 니들 |
US11135415B2 (en) | 2016-04-07 | 2021-10-05 | Labnpeople Co., Ltd. | Microneedle using biodegradable metal |
WO2017176077A1 (ko) * | 2016-04-07 | 2017-10-12 | 랩앤피플주식회사 | 생체분해성 금속을 이용한 마이크로 니들 |
KR102114984B1 (ko) | 2016-04-07 | 2020-05-26 | 랩앤피플주식회사 | 생체분해성 금속을 이용한 마이크로 니들 |
KR102114472B1 (ko) * | 2016-04-07 | 2020-05-22 | 랩앤피플주식회사 | 생체분해성 금속을 이용한 마이크로 니들 |
CN109069814A (zh) * | 2016-04-07 | 2018-12-21 | 实验室和人们 | 利用可生物降解金属的微针 |
CN107460372B (zh) * | 2016-06-02 | 2019-06-25 | 北京大学 | 一种Zn-Mn系锌合金及其制备方法与应用 |
CN107456601B (zh) * | 2016-06-02 | 2020-05-05 | 北京大学 | 一种Zn-Cu系锌合金及其制备方法与应用 |
CN107460371B (zh) * | 2016-06-02 | 2019-01-22 | 北京大学 | 一种Zn-Li系锌合金及其制备方法与应用 |
CN107460372A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn‑Mn系锌合金及其制备方法与应用 |
CN107460371A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn-Li系锌合金及其制备方法与应用 |
CN107456610A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn-Ag系锌合金及其制备方法与应用 |
CN107456601A (zh) * | 2016-06-02 | 2017-12-12 | 北京大学 | 一种Zn-Cu系锌合金及其制备方法与应用 |
CN106676327A (zh) * | 2017-03-14 | 2017-05-17 | 郑州大学 | 一种新型可生物降解Zn‑Mg‑Nd锌合金植入材料及其制备方法 |
CN107855528A (zh) * | 2017-10-31 | 2018-03-30 | 太原理工大学 | 一种多孔锌镁合金/羟基磷灰石复合材料的制备方法 |
CN107855528B (zh) * | 2017-10-31 | 2019-10-08 | 太原理工大学 | 一种多孔锌镁合金/羟基磷灰石复合材料的制备方法 |
CN108577922A (zh) * | 2018-02-26 | 2018-09-28 | 天津理工大学 | 一种可降解锌合金腹腔镜止血夹及其制备方法 |
CN108411158A (zh) * | 2018-03-05 | 2018-08-17 | 中国科学院宁波工业技术研究院慈溪生物医学工程研究所 | 一种生物可降解的Zn-Mg-Zr合金材料、制备方法及应用 |
CN108411158B (zh) * | 2018-03-05 | 2019-10-15 | 中国科学院宁波工业技术研究院慈溪生物医学工程研究所 | 一种生物可降解的Zn-Mg-Zr合金材料、制备方法及应用 |
CN108277386A (zh) * | 2018-03-23 | 2018-07-13 | 北京大学 | 一种Zn-Li-Mg系锌合金及其制备方法与应用 |
CN109097629A (zh) * | 2018-09-21 | 2018-12-28 | 北京科技大学 | 一种可生物降解Zn-Mo系锌合金及其制备方法 |
CN109097629B (zh) * | 2018-09-21 | 2021-01-15 | 北京科技大学 | 一种可生物降解Zn-Mo系锌合金及其制备方法 |
CN109938818B (zh) * | 2019-01-11 | 2021-01-08 | 中国医学科学院北京协和医院 | 可降解的镁合金髌骨爪及其制备方法 |
CN109938818A (zh) * | 2019-01-11 | 2019-06-28 | 中国医学科学院北京协和医院 | 可降解的镁合金髌骨爪及其制备方法 |
CN110273084B (zh) * | 2019-07-24 | 2020-09-08 | 西安交通大学 | 一种可生物降解锌合金的制备方法 |
CN110273084A (zh) * | 2019-07-24 | 2019-09-24 | 西安交通大学 | 一种可生物降解锌合金的制备方法 |
WO2021057140A1 (zh) * | 2019-09-23 | 2021-04-01 | 上海交通大学 | 医用锌基材料表面的镁-磷生物相容性涂层及制备和用途 |
CN111020254B (zh) * | 2019-11-19 | 2021-04-06 | 河海大学 | 一种低合金化高强韧易编织可降解医用锌合金丝材及其制备方法 |
CN111020246A (zh) * | 2019-11-19 | 2020-04-17 | 河海大学 | 一种基于超细三相共晶组织增强的高强韧医用生物可降解锌合金及其制备方法 |
CN111020254A (zh) * | 2019-11-19 | 2020-04-17 | 河海大学 | 一种低合金化高强韧易编织可降解医用锌合金丝材及其制备方法 |
CN111331128A (zh) * | 2020-04-16 | 2020-06-26 | 长沙镁捷新材料科技有限公司 | 一种通过金属粉末烧结制备锌合金可降解材料的方法 |
CN111778428B (zh) * | 2020-07-16 | 2022-01-28 | 扬州大学 | 一种Mg-Zn-Sr纳米晶及其制备方法 |
CN111778428A (zh) * | 2020-07-16 | 2020-10-16 | 扬州大学 | 一种Mg-Zn-Sr纳米晶及其制备方法 |
CN111876633A (zh) * | 2020-07-31 | 2020-11-03 | 湖南华耀百奥医疗科技有限公司 | 一种医用可降解高熵合金及其制备方法与应用 |
CN112899527A (zh) * | 2021-01-20 | 2021-06-04 | 湖南华锐科技集团股份有限公司 | 一种可降解锌合金棒材及其制备方法 |
CN112899527B (zh) * | 2021-01-20 | 2022-04-08 | 湖南华锐科技集团股份有限公司 | 一种可降解锌合金棒材及其制备方法 |
CN113416867A (zh) * | 2021-06-16 | 2021-09-21 | 东北大学 | 一种可用于可降解心血管支架的锌合金管材制备方法 |
CN114086030A (zh) * | 2021-11-22 | 2022-02-25 | 江苏时代铭阳生物新技术研究院有限公司 | 一种可降解高相容性的生物医用材料及其制备方法 |
CN114836653A (zh) * | 2022-04-20 | 2022-08-02 | 柳州华锡有色设计研究院有限责任公司 | 一种Zn-Al-Mg-RE热镀合金及其制备方法 |
CN114717447A (zh) * | 2022-05-19 | 2022-07-08 | 中南大学 | 一种超细晶生物可降解锌合金及其制备方法和应用 |
CN115181874A (zh) * | 2022-08-04 | 2022-10-14 | 北京科技大学 | 一种在锌合金表面生成碳酸盐保护层的方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104212998B (zh) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104212998B (zh) | 一种Zn‑Mg系锌合金及其制备方法与应用 | |
CN104195369B (zh) | 一种Zn-Ca系锌合金及其制备方法与应用 | |
CN104195368B (zh) | 一种Zn-Sr系锌合金及其制备方法与应用 | |
Jia et al. | In vitro and in vivo studies of Zn-Mn biodegradable metals designed for orthopedic applications | |
CN107460371B (zh) | 一种Zn-Li系锌合金及其制备方法与应用 | |
CN101015711B (zh) | 一种可体液降解的医用植入体及其制备方法 | |
CN107456610B (zh) | 一种Zn-Ag系锌合金及其制备方法与应用 | |
CN107456601B (zh) | 一种Zn-Cu系锌合金及其制备方法与应用 | |
CN104911427B (zh) | 一种Mg‑Ca‑Sr‑Zn系镁合金及其制备方法与应用 | |
CN107460372B (zh) | 一种Zn-Mn系锌合金及其制备方法与应用 | |
CN108315583B (zh) | 一种Zn-Li-Mn系锌合金及其制备方法与应用 | |
CN102580143A (zh) | 医用可降解吸收Mg-Sr系镁合金植入体及其制备方法 | |
CN102552973A (zh) | 医用可降解吸收Mg-Sr-Ca系镁合金植入体及其制备方法 | |
EP2229189A1 (en) | Implant for tissue engineering | |
CN108277386A (zh) | 一种Zn-Li-Mg系锌合金及其制备方法与应用 | |
CN106606801B (zh) | 一种Zn-ZnO系锌合金及其制备方法与应用 | |
CN102978495A (zh) | 一种Mg-Sr-Zn系合金及其制备方法 | |
CN106606800B (zh) | 一种Zn-Fe系锌合金及其制备方法与应用 | |
CN113106295A (zh) | 一种可降解生物医用材料Zn-Si-X系锌合金及制备方法 | |
AU2020104227A4 (en) | Zinc-Calcium alloy series and preparation method and application thereof | |
CN106606806B (zh) | 一种Zn-Mg1Ca系锌合金及其制备方法与应用 | |
CN111676390B (zh) | 一种Zn-Ga系合金及其制备方法与应用 | |
CN108714252B (zh) | 体内可控降解的镁合金固定螺钉的制备方法 | |
Xiao et al. | Investigation of zinc-silver alloys as biodegradable metals for orthopedic applications | |
AU2020101744A4 (en) | A Zn-Ga series alloy and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210826 Address after: 410600 Jinzhou North Road, Ningxiang high tech Industrial Park, Changsha, Hunan, 001 Patentee after: HUNAN HUAYAO BAIAO MEDICAL TECHNOLOGY Co.,Ltd. Address before: 100871 No. 202 Cheng Fu Road, Haidian District, Beijing. Patentee before: Peking University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221221 Address after: 410600 room 205, building 1, Hunan University Science and Technology Industrial Park, No. 001, Jinzhou North Road, Ningxiang high tech Industrial Park, Changsha City, Hunan Province Patentee after: Hunan Huaxiang Medical Technology Co.,Ltd. Address before: 410600 Jinzhou North Road, Ningxiang high tech Industrial Park, Changsha, Hunan, 001 Patentee before: HUNAN HUAYAO BAIAO MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP02 | Change in the address of a patent holder |
Address after: No. 58 Jinshui West Road, Ningxiang High tech Industrial Park, Changsha City, Hunan Province, 410604 Patentee after: Hunan Huaxiang Medical Technology Co.,Ltd. Address before: 410600 room 205, building 1, Hunan University Science and Technology Industrial Park, No. 001, Jinzhou North Road, Ningxiang high tech Industrial Park, Changsha City, Hunan Province Patentee before: Hunan Huaxiang Medical Technology Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |